Vifor Pharma AG
VIFN | SW
Overview
Corporate Details
- ISIN(s):
- CH0364749348
- LEI:
- 529900KO6CN2D9OE1F19
- Country:
- Switzerland
- Address:
- Rechenstrasse 37, 9014 St. Gallen
- Website:
- https://www.viforpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines. The Group also has a focus on the management of conditions in nephrology, cardiology and rare diseases. Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Vifor Pharma AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Vifor Pharma AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Vifor Pharma AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-09 | N/A | Executive member | Sell | None | 4,335,210.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,951,125.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,851,300.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 1,535,160.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,450,515.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 920,205.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 530,310.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 382,140.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 330,495.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 287,925.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
MUROMACHI CHEMICALS INC. | Japan | 4885 | |
|
NANO MRNA Co.,Ltd. | Japan | 4571 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX |